Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 8276 - 8300 of 10904 in total
Experimental
Matched Name: … ETHYL 4-[(4-CHLOROPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE …
Matched Iupac: … ethyl 4-[(4-chloropyridin-2-yl)amino]piperidine-1-carboxylate …
Experimental
Matched Name: … ETHYL 4-[(4-METHYLPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE …
Matched Iupac: … ethyl 4-[(4-methylpyridin-2-yl)amino]piperidine-1-carboxylate …
Experimental
Matched Name: … [4-(4-PHENYL-PIPERIDIN-1-YL)-BENZENESULFONYLAMINO]-ACETIC ACID …
Matched Iupac: … 2-[4-(4-phenylpiperidin-1-yl)benzenesulfonamido]acetic acid …
Investigational
Matched Synonyms: … 2'-Fluoro-5-methyl-beta-L-arabinofuranosyluracil …
Matched Iupac: … 1-[(2S,3R,4S,5S)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-1,2,3,4-tetrahydropyrimidine …
Investigational
Matched Iupac: … (2S)-2-amino-4-{[(1R)-1-[(carboxymethyl)carbamoyl]-2-(nitrososulfanyl)ethyl]carbamoyl}butanoic acid …
Vintafolide is a folate-targeted chemotherapeutic conjugate (folate vitamin + vinca alkaloid) in clinical stage development as a treatment for folate-receptor positive cancers.
Investigational
Matched Iupac: … 13.3.1.0^{4,12}.0^{5,10}]nonadeca-4(12),5,7,9-tetraen-13-yl]-10,11-dihydroxy-5-methoxy-8-methyl-8,16- ... ,12R,19R)-12-ethyl-4-[(1R,13S,15R,17S)-17-ethyl-17-hydroxy-13-(methoxycarbonyl)-1,11-diazatetracyclo[ ... (2S)-2-[(4-{[(2-amino-4-oxo-4,8-dihydropteridin-6-yl)methyl]amino}phenyl)formamido]-4-{[(1S)-1-{[(1S) ... -4-carbamimidamido-1-{[(1S)-2-carboxy-1-{[(1S)-2-carboxy-1-{[(1R)-1-carboxy-2-{[2-({N'-[(1R,9R,10S,11R …
Experimental
Matched Synonyms: … (S)-Hexahydropyrrolo(1,2-a)pyrazine-1,4-dione-4-17O …
Experimental
Disitamab vedotin is an antibody-drug conjugate drug targeting human epidermal growth factor receptor 2 (HER2). It is currently being investigated for cancers.
Investigational
Investigational
Matched Name: … 4-[211At]-L-phenylalanine …
CT-2584 has been used in trials studying the treatment of Prostate Cancer.
Investigational
Renzapride is currently in Phase III clinical development in the United States for the treatment of constipation-predominant irritable bowel syndrome (IBS-C). It has been suggested that renzapride is effective in the treatment of irritable bowel syndrome with alternating stool pattern. It is being developed by Alizyme of the UK.
Investigational
Matched Iupac: … 4-amino-N-{1-azabicyclo[3.3.1]nonan-4-yl}-3-chloro-2-methoxybenzamide …
Matched Categories: … Serotonin 5-HT4 Receptor Agonists …
Experimental
Matched Iupac: … 3-(4-carbamimidoylphenyl)-2-oxopropanoic acid …
Experimental
Matched Iupac: … (2S)-3-phenyl-2-(sulfamoylamino)propanoic acid …
Experimental
Matched Iupac: … ethyl (1S,2R)-2-(dimethylamino)-1-phenylcyclohex-3-ene-1-carboxylate …
Matched Mixtures name: … TILIDIN 50/4 RETARD 1A PHA ... TILIDIN 50/4 RETARD 1A PHA ... TILIDIN 50/4 RETARD 1A PHA …
Experimental
Matched Iupac: … ethyl (1S,2R)-2-(dimethylamino)-1-phenylcyclohex-3-ene-1-carboxylate …
Experimental
Matched Synonyms: … 4-trifluoromethylphenol ... 4-hydroxybenzotrifluoride …
Matched Name: … 4-(trifluoromethyl)phenol …
Matched Iupac: … 4-(trifluoromethyl)phenol …
Investigational
Experimental
Matched Name: … 4-Fluorophenethyl Alcohol …
Matched Iupac: … 2-(4-fluorophenyl)ethan-1-ol …
Experimental
Matched Name: … TACRINE(8)-4-AMINOQUINOLINE …
Matched Iupac: … N1-(quinolin-4-yl)-N8-(1,2,3,4-tetrahydroacridin-9-yl)octane-1,8-diamine …
Experimental
Matched Name: … 2-Nonyl-4-quinolinol 1-oxide …
Matched Iupac: … 4-hydroxy-2-nonylquinolin-1-ium-1-olate …
Displaying drugs 8276 - 8300 of 10904 in total